Financhill
Back

Novo Nordisk AS Vs. Genmab AS Industry Stock Comparison

Sell
44

NONOF
Novo Nordisk AS

Last Price:
$87.40
Seasonality Move:
4.97%
Buy
60

GMAB
Genmab AS

Last Price:
$22.35
Seasonality Move:
16.6%
Sell
44
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $87.40. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Genmab AS (GMAB) is a Buy

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $22.34. The Score for GMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • GMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $87.40
    The current trend is relatively stagnant and NONOF is experiencing slight selling pressure.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $22.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.21 Sell
Relative Strength Index (14 RSI): 55.26 Buy
Chaikin Money Flow: -491 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.86 - 85.92) Buy
Bollinger Bands (100): (86.07 - 113.91) Sell

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 65.39 Buy
Chaikin Money Flow: 907642 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.3 - 21.58) Buy
Bollinger Bands (100): (20.23 - 22.97) Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.26 Buy
20-day SMA: 83.91 Buy
50-day SMA: 88.56 Sell
200-day SMA: 117.52 Sell
8-day EMA: 83.46 Buy
20-day EMA: 83.86 Buy
50-day EMA: 89.08 Sell
200-day EMA: 106.82 Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.17 Buy
20-day SMA: 20.25 Buy
50-day SMA: 20.74 Buy
200-day SMA: 24.41 Sell
8-day EMA: 21.41 Buy
20-day EMA: 20.77 Buy
50-day EMA: 20.94 Buy
200-day EMA: 24.06 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $5.18 per share, an increase this year of $0.23 per share, and an increase next year of $0.28 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):